Results 221 to 230 of about 13,417,294 (339)

Editorial: Micronutrients and metabolic diseases - volume II. [PDF]

Front Nutr
Li J, Yang A, Luo Y, An P.
europepmc   +1 more source

Inter-laboratory proficiency tests to detect viral fish diseases. [PDF]

, 2009
Kahns, Søren, Nicolajsen, Nicole, Olesen, Niels Jørgen, Skall, Helle Frank   +3 more
core   +1 more source

Calcium regulation and Alzheimer's disease

, 2014
Deepthi Rapaka, Veera Raghavulu Bitra, Jayaram Reddy Medapati, Annapurna Akula   +3 more
openalex   +1 more source

Immunoprophylaxis of experimental Mycoplasma pneumoniae disease: effect of aerosol particle size and site of deposition of M. pneumoniae on the pattern of respiratory infection, disease, and immunity in hamsters [PDF]

, 1977
J V Jemski, C M Hetsko, Charles M. Helms, Michael Grizzard, J. S. Walker, Robert M. Chanock   +5 more
openalex   +1 more source

Predictors of response and rational combinations for the novel MCL‐1 inhibitor MIK665 in acute myeloid leukemia

Molecular Oncology, EarlyView.
This study characterizes the responses of primary acute myeloid leukemia (AML) patient samples to the MCL‐1 inhibitor MIK665. The results revealed that monocytic differentiation is associated with MIK665 sensitivity. Conversely, elevated ABCB1 expression is a potential biomarker of resistance to the treatment, which can be overcome by the combination ...
Joseph Saad, Rhiannon Newman, Elmira Khabusheva, Sofia Aakko, Eric Durand, Mahesh Tambe, Heikki Kuusanmäki, Alun Parsons, Juho J. Miettinen, Komal Kumar Javarappa, Ezgi June Olgac, Nemo Ikonen, Mika Kontro, Kimmo Porkka, Heiko Maacke, Janghee Woo, Ensar Halilovic, Caroline A. Heckman   +17 more
wiley   +1 more source

Feasibility of a ctDNA multigenic panel for non‐small‐cell lung cancer early detection and disease surveillance

Molecular Oncology, EarlyView.
Plasma‐based detection of actionable mutations is a promising approach in lung cancer management. Analysis of ctDNA with a multigene NGS panel identified TP53, KRAS, and EGFR as the most frequently altered, with TP53 and KRAS in treatment‐naïve patients and TP53 and EGFR in previously treated patients.
Giovanna Maria Stanfoca Casagrande, Marcela de Oliveira Silva, Mariana Bisarro dos Reis, Rodrigo de Oliveira Cavagna, Luciane Sussuchi, Icaro Alves Pinto, Natalia Zampieri Pontes, Rodrigo Sampaio Chiarantano, Flavio Augusto Ferreira da Silva, Pedro de Marchi, Letícia Ferro Leal, Rui M. Reis   +11 more
wiley   +1 more source

Beyond Borders-Tackling Neglected Tropical Viral Diseases. [PDF]

Trop Med Infect Dis
Prpić J.
europepmc   +1 more source

Vaccines against sexually transmitted diseases [PDF]

, 2003
BonDurant, Robert H, Campero, Carlos M, Corbeil, Lynette B, Rhyan, Jack C   +3 more
core   +2 more sources

Retarding the progression of chronic kidney disease with renin angiotensin system blockade

, 2012
RA Annigeri, M Limesh, Mani Mk, PC Kowdle, BSubba Rao, Sowmya Balasubramanian, R. Seshadri   +6 more
openalex   +1 more source

Aggressive prostate cancer is associated with pericyte dysfunction

Molecular Oncology, EarlyView.
Tumor‐produced TGF‐β drives pericyte dysfunction in prostate cancer. This dysfunction is characterized by downregulation of some canonical pericyte markers (i.e., DES, CSPG4, and ACTA2) while maintaining the expression of others (i.e., PDGFRB, NOTCH3, and RGS5).
Anabel Martinez‐Romero, Ane Martinez‐Larrinaga, Joaquim Grego‐Bessa, Saioa Garcia‐Longarte, Hielke van Splunder, Ianire Astobiza, Amaia Ercilla, Laura Bozal‐Basterra, Isabel Mendizabal, Pilar Villacampa, Arkaitz Carracedo, Mariona Graupera   +11 more
wiley   +1 more source